PABVX | VMVAX | PABVX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 13 years | - |
Gain YTD | 17.314 | 18.129 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | N/A | N/A | - |
Annual Yield % from dividends | 1.01 | 2.14 | 47% |
Returns for 1 year | 26.47 | 31.88 | 83% |
Returns for 3 years | 0.51 | 15.18 | 3% |
Returns for 5 years | 36.92 | 48.70 | 76% |
Returns for 10 years | 24.35 | 99.34 | 25% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MMKBX | 22.32 | 0.31 | +1.41% |
Morgan Stanley Inst Emerging Mkts A | |||
AIISX | 31.42 | 0.35 | +1.13% |
Virtus International S/C R6 | |||
KTRZX | 10.20 | 0.11 | +1.09% |
DWS Global Income Builder R6 | |||
TRHZX | 157.22 | 1.16 | +0.74% |
T. Rowe Price Equity Index 500 Z | |||
JEPSX | 14.87 | 0.02 | +0.13% |
JPMorgan Equity Premium Income R5 |